Post Hoc Analysis Of The Patricia Randomized Trial Of The Efficacy Of Human Papillomavirus Type 16 (hpv-16)/hpv-18 As04-adjuvanted Vaccine Against Incident And Persistent Infection With Nonvaccine Oncogenic Hpv Types Using An Alternative Multiplex Type-specific Pcr Assay For Hpv Dna.

The efficacy of the human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against cervical infections with HPV in the Papilloma Trial against Cancer in Young Adults (PATRICIA) was evaluated using a combination of the broad-spectrum L1-based SPF10 PCR-DNA enzyme immunoassay (DEIA)/line probe assay (LiPA25) system with type-specific PCRs for HPV-16 and -18. Broad-spectrum PCR assays may underestimate the presence of HPV genotypes present at relatively low concentrations in multiple infections, due to competition between genotypes. Therefore, samples were retrospectively reanalyzed using a testing algorithm incorporating the SPF10 PCR-DEIA/LiPA25 plus a novel E6-based multiplex type-specific PCR and reverse hybridization assay (MPTS12 RHA), which permits detection of a panel of nine oncogenic HPV genotypes (types 16, 18, 31, 33, 35, 45, 52, 58, and 59). For the vaccine against HPV types 16 and 18, there was no major impact on estimates of vaccine efficacy (VE) for incident or 6-month or 12-month persistent infections when the MPTS12 RHA was included in the testing algorithm versus estimates with the protocol-specified algorithm. However, the alternative testing algorithm showed greater sensitivity than the protocol-specified algorithm for detection of some nonvaccine oncogenic HPV types. More cases were gained in the control group than in the vaccine group, leading to higher point estimates of VE for 6-month and 12-month persistent infections for the nonvaccine oncogenic types included in the MPTS12 RHA assay (types 31, 33, 35, 45, 52, 58, and 59). This post hoc analysis indicates that the per-protocol testing algorithm used in PATRICIA underestimated the VE against some nonvaccine oncogenic HPV types and that the choice of the HPV DNA testing methodology is important for the evaluation of VE in clinical trials. (This study has been registered at ClinicalTrials.gov under registration no. NCT00122681.).

Brian Laver at LBJ demonstration

Brian Laver speaking at the demonstration to protest the visit of President Lyndon Johnson to Brisbane during the Vietnam War in January 1966. Jack Sherrington can be seen on extreme right of photograph.

Tradução do glossário da obra "Revising and editing for translators" de Brian Mossop

Brian Robert Mossop nasceu a 9 de Março de 1946 em Londres, Inglaterra, mas vive actualmente no Canadá, onde é tradutor profissional a tempo inteiro; ensina tradução a tempo parcial, dirige oficinas sobre desenvolvimento profissional e escreve sobre Tradução.

The early ceramics of the Inca heartland / Brian S. Bauer.

n.s. no.31(1999)

Marques de biblioteca: Robert Brian Tate

Explicació del motius que Robert Brian Tate podia tenir per a triar l’humanista quatrecentista Joan Margarit i Pau com a figura del seu ex-libris

Report on the City of Harper for the period July 1, 2008 through December 31, 2009

Report on the City of Harper for the period July 1, 2008 through December 31, 2009

Strange nonchaotic attractors in Harper maps

We study the existence of strange nonchaotic attractors (SNA) in the family of Harper maps. We prove that for a set of parameters of positive measure, the map possesses a SNA. However, the set is nowhere dense. By changing the parameter arbitrarily small amounts, the attractor is a smooth curve and not a SNA.

Agreed-upon procedures report on the City of Harper, Iowa for the period November 1, 2013 through October 31, 2014

Agreed-upon procedures report on the City of Harper, Iowa for the period November 1, 2013 through October 31, 2014